These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 18F-FDG-PET/CT of peritoneal tumors: a pictorial essay. Dubreuil J; Giammarile F; Rousset P; Rubello D; Colletti PM; Glehen O; Skanjeti A Nucl Med Commun; 2017 Jan; 38(1):1-9. PubMed ID: 27820721 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of recurrence in gastric carcinoma: Comparison of contrast-enhanced computed tomography and positron emission tomography/computed tomography. Kim JH; Heo SH; Kim JW; Shin SS; Min JJ; Kwon SY; Jeong YY; Kang HK World J Gastroenterol; 2017 Sep; 23(35):6448-6456. PubMed ID: 29085194 [TBL] [Abstract][Full Text] [Related]
4. Role of [ Zhao L; Pang Y; Luo Z; Fu K; Yang T; Zhao L; Sun L; Wu H; Lin Q; Chen H Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1944-1955. PubMed ID: 33415432 [TBL] [Abstract][Full Text] [Related]
7. 68Ga-FAPI Outperforms 18F-FDG PET/CT in Identifying Bone Metastasis and Peritoneal Carcinomatosis in a Patient With Metastatic Breast Cancer. Pang Y; Zhao L; Chen H Clin Nucl Med; 2020 Nov; 45(11):913-915. PubMed ID: 32910045 [TBL] [Abstract][Full Text] [Related]
8. Detection of stomach peritoneal infiltration in colorectal cancer using PET-FDG. Domínguez Grande ML; Bueno JG; Fernández JP; Suárez AM; Zomeño M; Oromendía AO; Kosvintseva O; Pozo MA Clin Nucl Med; 2005 Feb; 30(2):122-3. PubMed ID: 15647685 [No Abstract] [Full Text] [Related]
9. Fibroblast Activation Protein Inhibitor PET/CT in Gastric Cancer. Watabe T; Giesel FL PET Clin; 2023 Jul; 18(3):337-344. PubMed ID: 37030982 [TBL] [Abstract][Full Text] [Related]
10. 68Ga-ZHER2 PET/CT Reveals HER2-Positive Metastatic Gastric Cancer With Better Image Quality Than 18F-FDG. Zhou N; Guo X; Yang M; Zhu H; Yang Z Clin Nucl Med; 2020 Feb; 45(2):e101-e102. PubMed ID: 31833926 [TBL] [Abstract][Full Text] [Related]
11. Fibroblast Activation Protein-Targeted PET/CT with Luo Y; Pan Q; Yang H; Peng L; Zhang W; Li F J Nucl Med; 2021 Feb; 62(2):266-271. PubMed ID: 32513902 [TBL] [Abstract][Full Text] [Related]
12. Editorial Comment: Use of Tirumani SH AJR Am J Roentgenol; 2023 Apr; 220(4):498. PubMed ID: 36382916 [No Abstract] [Full Text] [Related]
13. Peritoneal carcinomatosis: role of (18)F-FDG PET. Turlakow A; Yeung HW; Salmon AS; Macapinlac HA; Larson SM J Nucl Med; 2003 Sep; 44(9):1407-12. PubMed ID: 12960184 [TBL] [Abstract][Full Text] [Related]
14. Will FAPI PET/CT Replace FDG PET/CT in the Next Decade? Counterpoint-No, Not So Fast! Moradi F; Iagaru A AJR Am J Roentgenol; 2021 Feb; 216(2):307-308. PubMed ID: 32755204 [No Abstract] [Full Text] [Related]
15. Will FAPI PET/CT Replace FDG PET/CT in the Next Decade? Point-An Important Diagnostic, Phenotypic, and Biomarker Role. Calais J; Mona CE AJR Am J Roentgenol; 2021 Feb; 216(2):305-306. PubMed ID: 32755205 [No Abstract] [Full Text] [Related]
16. Molecular Imaging of Peritoneal Carcinomatosis in Ovarian Carcinoma. Lee EYP; An H; Tse KY; Khong PL AJR Am J Roentgenol; 2020 Aug; 215(2):305-312. PubMed ID: 32551907 [No Abstract] [Full Text] [Related]
17. [Peritoneal carcinomatosis from ovarian cancer: role of 18F-FDG-PET/CT and CA125]. Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Stabile Ianora AA; Giganti M; Niccoli Asabella A Recenti Prog Med; 2012 Nov; 103(11):510-4. PubMed ID: 23096741 [TBL] [Abstract][Full Text] [Related]
19. The Application of [ Zhang H; An J; Wu P; Zhang C; Zhao Y; Tan D; Shi C; Ge X Contrast Media Mol Imaging; 2022; 2022():6596702. PubMed ID: 36051919 [TBL] [Abstract][Full Text] [Related]
20. Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue. Lopez-Lopez V; Cascales-Campos PA; Gil J; Frutos L; Andrade RJ; Fuster-Quiñonero M; Feliciangeli E; Gil E; Parrilla P Eur J Radiol; 2016 Oct; 85(10):1824-1828. PubMed ID: 27666623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]